JP2021517587A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021517587A5 JP2021517587A5 JP2020557373A JP2020557373A JP2021517587A5 JP 2021517587 A5 JP2021517587 A5 JP 2021517587A5 JP 2020557373 A JP2020557373 A JP 2020557373A JP 2020557373 A JP2020557373 A JP 2020557373A JP 2021517587 A5 JP2021517587 A5 JP 2021517587A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- tumor
- use according
- til
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 claims 17
- 230000004151 fermentation Effects 0.000 claims 17
- 206010028980 Neoplasm Diseases 0.000 claims 16
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 claims 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 8
- 230000000813 microbial effect Effects 0.000 claims 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 4
- 230000004913 activation Effects 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 235000014655 lactic acid Nutrition 0.000 claims 4
- 239000004310 lactic acid Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 241000894006 Bacteria Species 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 2
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 2
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 2
- 230000005809 anti-tumor immunity Effects 0.000 claims 2
- 210000000988 bone and bone Anatomy 0.000 claims 2
- 238000002512 chemotherapy Methods 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 201000004101 esophageal cancer Diseases 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 201000010536 head and neck cancer Diseases 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002458 infectious effect Effects 0.000 claims 2
- 230000002601 intratumoral effect Effects 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 230000001613 neoplastic effect Effects 0.000 claims 2
- 238000011275 oncology therapy Methods 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 206010038038 rectal cancer Diseases 0.000 claims 2
- 201000001275 rectum cancer Diseases 0.000 claims 2
- 230000004044 response Effects 0.000 claims 2
- 201000000849 skin cancer Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims 2
- 206010046766 uterine cancer Diseases 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 102000037982 Immune checkpoint proteins Human genes 0.000 claims 1
- 108091008036 Immune checkpoint proteins Proteins 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 230000008569 process Effects 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 235000013619 trace mineral Nutrition 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 claims 1
- 230000035899 viability Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024000217A JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862615300P | 2018-01-09 | 2018-01-09 | |
| US62/615,300 | 2018-01-09 | ||
| PCT/CN2019/070944 WO2019137384A1 (en) | 2018-01-09 | 2019-01-09 | Method of activating tumor-infiltrating lymphocytes (tils) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000217A Division JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021517587A JP2021517587A (ja) | 2021-07-26 |
| JP2021517587A5 true JP2021517587A5 (cg-RX-API-DMAC7.html) | 2022-01-11 |
Family
ID=67139037
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020557373A Pending JP2021517587A (ja) | 2018-01-09 | 2019-01-09 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
| JP2024000217A Pending JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000217A Pending JP2024050573A (ja) | 2018-01-09 | 2024-01-04 | 腫瘍浸潤リンパ球(tils)を活性化する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11179425B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3737395A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021517587A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111655272A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI817977B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019137384A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119868398A (zh) * | 2018-06-14 | 2025-04-25 | 株式会社明治 | 用于促进免疫检查点抑制疗法的组合物 |
| JP7856975B2 (ja) | 2022-09-12 | 2026-05-12 | 賢一郎 蓮見 | 抗腫瘍免疫応答増強剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020182274A1 (en) * | 2001-03-21 | 2002-12-05 | Kung-Ming Lu | Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| DE60134386D1 (de) | 2001-03-21 | 2008-07-24 | Microbio Co Ltd | Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt |
| JP2003335695A (ja) * | 2002-05-17 | 2003-11-25 | Nippon Bio Kk | 大豆発酵物よりなる免疫増強剤、抗腫瘍剤、加工食品および大豆発酵物の製造方法 |
| TWI252759B (en) | 2002-07-05 | 2006-04-11 | Microbio Co Ltd | Method of using fermented glycine max (L.) extract for enhancing natural killer cell activity |
| CN100352459C (zh) | 2004-07-15 | 2007-12-05 | 中天生物科技股份有限公司 | 发酵大豆萃取液在制备药物中的应用 |
| SG187554A1 (en) | 2010-07-20 | 2013-03-28 | Microbio Co Ltd | Use of a fermented soy extract for manufacture of a prebiotic composition |
| EP2659898B1 (en) * | 2010-12-28 | 2018-03-07 | Kirin Holdings Kabushiki Kaisha | Use of lactococcus bacteria in the treatment or prevention of viral infections |
| JP2015051970A (ja) | 2013-09-06 | 2015-03-19 | マイクロバイオ カンパニー, リミテッド | 化学療法を受けているがん患者向けのアジュバントを製造するための組成物 |
| EA201690912A1 (ru) * | 2013-11-05 | 2016-10-31 | Когнейт Биосервисис, Инк. | Комбинации ингибиторов контрольных точек и терапевтических средств для лечения рака |
| KR20180126053A (ko) * | 2016-03-30 | 2018-11-26 | 마이크로바이오 컴퍼니 엘티디. | 면역 체크포인트 조절제 및 공생 미생물군에 의한 발효 산물로의 병용 암 치료법 |
| EP3228701A1 (en) * | 2016-04-05 | 2017-10-11 | Fundación Centro Nacional de Investigaciones Oncológicas Carlos III | Method for preparing lymphocytes capable of infiltrating a solid tumor, lymphocytes obtainable by said method and uses thereof |
| CN112779217B (zh) * | 2021-03-29 | 2023-04-11 | 复旦大学附属中山医院 | 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法 |
-
2019
- 2019-01-09 TW TW108100871A patent/TWI817977B/zh active
- 2019-01-09 EP EP19738681.6A patent/EP3737395A4/en not_active Ceased
- 2019-01-09 US US16/243,325 patent/US11179425B2/en active Active
- 2019-01-09 WO PCT/CN2019/070944 patent/WO2019137384A1/en not_active Ceased
- 2019-01-09 EP EP25218977.4A patent/EP4755455A2/en active Pending
- 2019-01-09 JP JP2020557373A patent/JP2021517587A/ja active Pending
- 2019-01-09 CN CN201980007599.2A patent/CN111655272A/zh active Pending
-
2024
- 2024-01-04 JP JP2024000217A patent/JP2024050573A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109294985B (zh) | 一种用于nk细胞体外扩增的培养基体系及nk细胞体外扩增的方法 | |
| CN103756963B (zh) | 一种体外扩增nk细胞的方法 | |
| IL274584B2 (en) | Infiltrating lymphocyte expansion from fine needle aspirates and small biopsies | |
| CN105238754B (zh) | 一种高增殖力和高杀伤力nk细胞的体外培养方法 | |
| CN104781413B (zh) | 用于具有肺炎球菌血清型的荚膜多糖的生产方法 | |
| CN105039269A (zh) | 一种用于治疗非小细胞肺癌的新型病毒疫苗及其制备方法 | |
| CN112779217B (zh) | 一种高记忆表型肿瘤浸润t淋巴细胞的培养方法 | |
| CN106591232A (zh) | 一种高效的pd‑1‑cd8+t细胞的培养方法 | |
| RU2014147735A (ru) | Онколитические штаммы clostridium ghonii, способы получения и применения | |
| CN105505871B (zh) | 一种有效扩增cik且提高其特异性杀瘤能力的方法 | |
| CN107502591A (zh) | 一种浓度梯度rhIL‑2依赖的iNKT细胞扩增方法及其应用 | |
| JP2018531016A5 (cg-RX-API-DMAC7.html) | ||
| JP2018505666A5 (cg-RX-API-DMAC7.html) | ||
| CN111662870A (zh) | 卡介菌多糖核酸在cik细胞体外培养及制备肿瘤药物中的应用 | |
| US9950020B2 (en) | Extracts from fusarium oxysporum and use thereof | |
| CN110205293A (zh) | 一种加强型高效治疗肺癌的nk免疫细胞的制备方法及应用 | |
| CN112695014A (zh) | 一种扩增nk细胞的培养体系及其培养方法 | |
| CN104651312A (zh) | 一种高效免疫活性细胞CpG-DCIK的制备方法及应用 | |
| CN104906088B (zh) | 黄连素在制备治疗t细胞淋巴瘤的药物中的应用 | |
| CN105505870A (zh) | 免疫细胞培养方法以及人工滋养细胞在免疫细胞培养中的用途 | |
| CN105219728A (zh) | 一种用于激活乳腺癌特异性免疫反应的试剂盒 | |
| Peng et al. | Induction of cytotoxic T-lymphocyte responses using dendritic cells transfected with hepatocellular carcinoma mRNA | |
| WO2020037120A4 (en) | Il7-il15 txm compositions and methods | |
| VIDYA et al. | Spirulina, the boon of nature | |
| CN105219715A (zh) | 一种用于激活食管癌特异性免疫反应的试剂盒 |